Upgrade to SI Premium - Free Trial

Corvus Pharmaceuticals (CRVS) PT Raised to $33 at Oppenheimer

March 13, 2026 6:25 AM
(Updated - March 13, 2026 6:26 AM EDT)

Oppenheimer analyst Jeff Jones raised the price target on Corvus Pharmaceuticals ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change